Form 4 for MET MetLife
Accepted 2022-12-14 00:00:00 ET · period of report 2022-12-12 · accession 0001099219-22-000186 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-14 | 2022-12-12 | MET | Khalaf Michel | Pres, CEO, Dir | M - OptEx | $32.82 | +74.9K | 282.5K | +36% | +$2.46M |
| D | 2022-12-14 | 2022-12-12 | MET | Khalaf Michel | Pres, CEO, Dir | S - Sale+OE | $72.49 | -57.2K | 264.6K | -18% | -$4.15M |
| DM | 2022-12-14 | 2022-12-12 | MET | Khalaf Michel | Pres, CEO, Dir | M - OptEx | $0.00 | -74.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-12 | M | A | 39,322 | $34.33 | 321,819 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-12 | S | D | 57,201 | $72.49 | 264,618 | D | — | — | (F1) The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on December 12, 2022 and related tax obligations and fees. (F2) The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $72.38 to $72.865, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. |
| 3 | Common | Common Stock | 2022-12-12 | M | A | 35,616 | $31.15 | 282,497 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2022-12-12 | M | D | 39,322 | $0.00 | 0 | D | $34.33 · — to 2026-02-22 | 39,322 Common Stock | (F5) Includes 4,193 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options. (F6) The options become exercisable in three substantially equal installments on February 23, 2016, 2017 and 2018. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2022-12-12 | M | D | 35,616 | $0.00 | 0 | D | $31.15 · — to 2023-02-25 | 35,616 Common Stock | (F3) Includes 3,798 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options. (F4) The options become exercisable in three substantially equal installments on February 26, 2014, 2015 and 2016. |